No quick-fix regulatory solution for device software
This article was originally published in Clinica
There is unlikely to be a quick formula to apply to software validation to ensure compliance with EU and FDA regulations because technology is moving at such a fast rate. That was the conclusion reached last month when the Medical Devices Quality Group (MDQG), a special interest group at the Institute of Quality Assurance, held a medical devices software validation workshop in London. So says Angie Glover, of the medical device consultancy, Quintiles Consulting.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.